Dexaflip 1.5 Tablet contains Dexamethasone 1.5mg, a low-dose corticosteroid widely used for anti-inflammatory, immunosuppressive, and anti-allergic treatments. It helps manage inflammation, reduce immune overactivity, and alleviate allergic symptoms effectively in mild to moderate clinical conditions.
Dexamethasone’s efficacy in controlling tissue swelling, modulating immune responses, and managing allergies makes it a preferred option in hospital wards, clinics, and outpatient departments. Its predictable pharmacological action ensures reliable therapeutic outcomes even at lower doses.
For distributors and hospital suppliers, Dexaflip 1.5 Tablet is a high-demand corticosteroid, routinely prescribed in internal medicine, ENT, pulmonology, and allergy management departments. Steady prescription patterns provide continuous market movement and repeat procurement opportunities.
Including Dexaflip 1.5 Tablet in your portfolio strengthens your anti-inflammatory and immunosuppressive therapy segment, opening supply opportunities across hospital procurement, institutional orders, government tenders, export channels, and third-party manufacturing projects. Its widespread clinical use makes it a profitable and strategically important product for pharmaceutical distributors.